Historically, studies to identify cancer causing genetic alterations and interactions have been limited to single genes or proteins. Yet, alterations of biological processes involves coordinated changes in the expression of dozens or more genes. With the availability of the complete sequence of the human and mouse genomes, experimentalists can now use global approaches that simultaneously examine multitudes of genes. In addition, the ability to collect these rich data from clinical specimens is growing rapidly. These developments necessitate the integration of genetics and genomics with clinical medicine. To manage and analyze the complex data sets generated, translational research must be facile with biomedical informatics, bioinformatics and computation biology. In response to these needs, the UNC Breast SPORE has developed Core 1, the Genomics, Genotyping and Bioinformatics shared resource. Under the experienced leadership of the SPORE Co-Pi, Dr. Charles Perou and Dr.Steve Marron, SPORE Core 1 brings together three critical services - high quality DMA microarray services, high-throughput genotyping, andrelated Bioinformatics - andfocuses them ontranslational breast cancer research. Four proposed SPORE projects (1, 3, 4, 5) plan to use the Core. These three Core services are part of two UNC Lineberger Comprehensive Cancer Center shared resources - Genomics &Bioinformatics and the Mammalian High Throughput Genotyping facility. In both these cores, the needs of Breast SPORE investigators and their studies have spurred development of methods and equipment upgrades that benefit and stimulate other Cancer Center research. By supporting key personnel in these two Cancer Center cores, the UNC Breast SPORE is assuring priority service and performance. Dr. Perou's expertise and experience with these services, his leadership in the Cancer Center Genomics & Bioinformatics Core, and Dr. Earp's dual role as Breast SPORE and Cancer Center Director mean that this SPORE Core is integrated into the Cancer Center structure and appropriately providing services to SPORE investigators.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
5P50CA058223-18
Application #
8135452
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2010-08-01
Budget End
2011-07-31
Support Year
18
Fiscal Year
2010
Total Cost
$129,690
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
McRee, Autumn J; Marcom, Paul K; Moore, Dominic T et al. (2018) A Phase I Trial of the PI3K Inhibitor Buparlisib Combined With Capecitabine in Patients With Metastatic Breast Cancer. Clin Breast Cancer 18:289-297
DeBono, Nathan L; Robinson, Whitney R; Lund, Jennifer L et al. (2018) Race, Menopausal Hormone Therapy, and Invasive Breast Cancer in the Carolina Breast Cancer Study. J Womens Health (Larchmt) 27:377-386
Nasarre, Patrick; Bonilla, Ingrid V; Metcalf, John S et al. (2018) TRAF3-interacting protein 3, a new oncotarget, promotes tumor growth in melanoma. Melanoma Res 28:185-194
Pearce, Oliver M T; Delaine-Smith, Robin M; Maniati, Eleni et al. (2018) Deconstruction of a Metastatic Tumor Microenvironment Reveals a Common Matrix Response in Human Cancers. Cancer Discov 8:304-319
Williams, Lindsay A; Nichols, Hazel B; Hoadley, Katherine A et al. (2018) Reproductive risk factor associations with lobular and ductal carcinoma in the Carolina Breast Cancer Study. Cancer Causes Control 29:25-32
Couture, Heather D; Williams, Lindsay A; Geradts, Joseph et al. (2018) Image analysis with deep learning to predict breast cancer grade, ER status, histologic subtype, and intrinsic subtype. NPJ Breast Cancer 4:30
Lei, Jonathan T; Shao, Jieya; Zhang, Jin et al. (2018) Functional Annotation of ESR1 Gene Fusions in Estrogen Receptor-Positive Breast Cancer. Cell Rep 24:1434-1444.e7
Troester, Melissa A; Sun, Xuezheng; Allott, Emma H et al. (2018) Racial Differences in PAM50 Subtypes in the Carolina Breast Cancer Study. J Natl Cancer Inst 110:
Williams, Michelle M; Lee, Linus; Werfel, Thomas et al. (2018) Intrinsic apoptotic pathway activation increases response to anti-estrogens in luminal breast cancers. Cell Death Dis 9:21
Allott, Emma H; Geradts, Joseph; Cohen, Stephanie M et al. (2018) Frequency of breast cancer subtypes among African American women in the AMBER consortium. Breast Cancer Res 20:12

Showing the most recent 10 out of 598 publications